CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102. A total of 21 filers reported holding CNS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,000 | -50.0% | 5,500 | -0.2% | 0.00% | – |
| Q3 2021 | $8,000 | -68.0% | 5,513 | -55.9% | 0.00% | – |
| Q2 2021 | $25,000 | -16.7% | 12,500 | 0.0% | 0.00% | – |
| Q1 2021 | $30,000 | +36.4% | 12,500 | 0.0% | 0.00% | – |
| Q4 2020 | $22,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q3 2020 | $22,000 | +450.0% | 12,500 | +514.3% | 0.00% | – |
| Q1 2020 | $4,000 | – | 2,035 | +3739.6% | 0.00% | – |
| Q4 2019 | $0 | – | 53 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 20,745 | $41,000 | 0.00% |
| Integrated Advisors Network LLC | 10,700 | $21,000 | 0.00% |
| Alpha Cubed Investments, LLC | 11,000 | $22,000 | 0.00% |
| Renaissance Technologies | 432,109 | $847,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11,061 | $22,000 | 0.00% |
| Sterling Financial Planning, Inc. | 600 | $1,000 | 0.00% |
| UBS Group AG | 4,676 | $9,000 | 0.00% |
| Capital Analysts, LLC | 1,000 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 5,000 | $10,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,000 | $4,000 | 0.00% |